Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced the appointment of Venkat R. Krishnamurthy, Ph.D., as Chief Scientific Officer. Dr.
The genetic modification therapy market presents key opportunities in developing specialized treatments for rare, inherited, ...
Scientists have transformed enigmatic cell structures, called vaults, into storage units for messenger-RNA molecules made in ...
Researchers explored a novel strategy involving CRISPR–Cas3 and investigated its potential using a mouse model of ...
Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...
The "Molecular Biology for the Non-molecular Biologist Training Course (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets.com's offering.Elevate your expertise in molecular ...
BK and CaV1.3 channels interact early during biogenesis, assembling intracellularly before membrane localization, indicating ...
This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...
HKU research projects receive HK$72 million funding under RGC schemes The University of Hong Kong (HKU) has achieved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback